# John Flavin

Populaarseimad podcastide jaod
Uuendatud:

Powering the Quantum Revolution with David Gunnarsson_e.084

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. David Gunnarsson, Chief Business Development Officer at Bluefors, the global leader in cryogenic measurement systems powering the future of quantum technology. With a background spanning quantum physics, low-temperature researc…

Where Engineering Meets Medicine with Tejal Desai_e.086

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Tejal Desai, Sorensen Family Dean of Engineering at Brown University and a nationally recognized leader in biomedical engineering, tissue engineering, and translational medicine. A member of both the National Academy of Enginee…

The FDA's Cancer Revolution with Richard Pazdur_e.087

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Richard Pazdur, one of the most influential figures in modern oncology and cancer drug development. As the founding director of the FDA's Oncology Center of Excellence and former director of the Office of Hematology and Oncolog…

Headlines to New Heights with Luke Timmerman_e.088

In this episode of Lab Rats to Unicorns, John Flavin sits down with Luke Timmerman, founder of the Timmerman Report and one of biotechnology’s most respected journalists and storytellers. For more than 25 years, Luke has chronicled the scientists, entrepreneurs, investors, and companies shaping the…

SpaceX Earnings Report… And What’s Next for the Pharma Trade 8/4/26

SpaceX on the move in after-hours trading on the back of its first earnings report since going public. Can investors expect SpaceX to blast off, or will the aerospace giant sink even further below its IPO price?Then, major Pharma earnings from giants like Pfizer and Merck beating Wall Street estima…

The Beehive State’s Biotech Boom with Andy Robertson_e.089

In this episode of Lab Rats to Unicorns, John Flavin sits down with Andy Robertson, executive director of BioHive Utah and a longtime leader in medical devices, diagnostics, commercialization, and life sciences ecosystem development. Over nearly three decades, Andy has worked across major healthcar…

Building the Quantum Network with Manish Singh & Sean Sullivan_e.090

In this episode of Lab Rats to Unicorns, John Flavin sits down with Manish Singh, co-founder and Chief Product Officer, and Sean Sullivan, co-founder and Chief Technology Officer of MemQ to explore the science, infrastructure, and entrepreneurship shaping the future of quantum technology. Manish a…

Rewriting the Code of Disease with Kiran Musunuru_e.091

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Kiran Musunuru, a cardiologist, geneticist, professor at the University of Pennsylvania, and leading expert in gene editing. Kiran’s research spans cardiovascular, metabolic, and rare genetic diseases, with a focus on turning a…

Putting Your Neck on the Line with Jeremy Levin_e.092

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Jeremy Levin, a physician, scientist, biotech executive, and longtime leader in the pharmaceutical industry. Jeremy has held senior roles across Genzyme, Novartis, Bristol-Myers Squibb, and Teva, and today serves as Executive C…

Disarming Staph with Dominique Missiakas & Vilasack Thammavongsa_e.093

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Vilasack Thammavongsa and Dr. Dominique Missiakas, co-founders of Immunartes, a biotechnology company developing new approaches to prevent serious Staphylococcus aureus infections. Dominique and Vilasack trace the scientific cu…